Bronchial thermoplasty: A new treatment paradigm for severe persistent asthma

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Patients with severe asthma represent only a minority of the total asthma population; however, they account for the majority of the mortality, morbidity, and health care-related cost of this chronic illness. Bronchial thermoplasty is a novel treatment modality that employs radiofrequency energy to alter the smooth muscles of the airways. This therapy represents a radical change in our treatment paradigm from daily repetitive dosing of medications to a truly long-term and potentially permanent attenuation of perhaps the most feared component of asthma - smooth muscle-induced bronchospasm. A large, multicentered, double-blinded, randomized controlled trial employed the unprecedented (but now industry standard for bronchoscopic studies) approach of using sham bronchoscopy as a control. It demonstrated that bronchial thermoplasty is safe, improved quality of life, and decreased frequency of severe exacerbations in the treatment group compared to the control group. Although the mechanism of action of bronchial thermoplasty is not currently completely understood, it should be considered as a valid and potentially valuable option for patients who have severe persistent asthma and who remain symptomatic despite inhaled corticosteroids and long-acting beta-2 agonists. Such patients should however be carefully evaluated at centers with expertise in managing severe asthma patients and with physicians who have experience with this promising new treatment modality.

Original languageEnglish (US)
Pages (from-to)184-193
Number of pages10
JournalClinical Reviews in Allergy and Immunology
Volume43
Issue number1-2
DOIs
StatePublished - Aug 2012

Fingerprint

Asthma
Smooth Muscle
Therapeutics
Bronchial Spasm
Cost of Illness
Bronchoscopy
Health Care Costs
Industry
Adrenal Cortex Hormones
Chronic Disease
Randomized Controlled Trials
Quality of Life
Morbidity
Physicians
Control Groups
Mortality
Population

Keywords

  • Airway smooth muscle
  • Bronchial thermoplasty
  • Radiofrequency energy
  • Refractory asthma
  • Severe asthma

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Bronchial thermoplasty : A new treatment paradigm for severe persistent asthma. / Cayetano, Katherine S.; Chan, Andrew; Albertson, Timothy E; Yoneda, Ken Y.

In: Clinical Reviews in Allergy and Immunology, Vol. 43, No. 1-2, 08.2012, p. 184-193.

Research output: Contribution to journalArticle

@article{8b20453e8b914d4d81807b455ee1a301,
title = "Bronchial thermoplasty: A new treatment paradigm for severe persistent asthma",
abstract = "Patients with severe asthma represent only a minority of the total asthma population; however, they account for the majority of the mortality, morbidity, and health care-related cost of this chronic illness. Bronchial thermoplasty is a novel treatment modality that employs radiofrequency energy to alter the smooth muscles of the airways. This therapy represents a radical change in our treatment paradigm from daily repetitive dosing of medications to a truly long-term and potentially permanent attenuation of perhaps the most feared component of asthma - smooth muscle-induced bronchospasm. A large, multicentered, double-blinded, randomized controlled trial employed the unprecedented (but now industry standard for bronchoscopic studies) approach of using sham bronchoscopy as a control. It demonstrated that bronchial thermoplasty is safe, improved quality of life, and decreased frequency of severe exacerbations in the treatment group compared to the control group. Although the mechanism of action of bronchial thermoplasty is not currently completely understood, it should be considered as a valid and potentially valuable option for patients who have severe persistent asthma and who remain symptomatic despite inhaled corticosteroids and long-acting beta-2 agonists. Such patients should however be carefully evaluated at centers with expertise in managing severe asthma patients and with physicians who have experience with this promising new treatment modality.",
keywords = "Airway smooth muscle, Bronchial thermoplasty, Radiofrequency energy, Refractory asthma, Severe asthma",
author = "Cayetano, {Katherine S.} and Andrew Chan and Albertson, {Timothy E} and Yoneda, {Ken Y}",
year = "2012",
month = "8",
doi = "10.1007/s12016-011-8295-6",
language = "English (US)",
volume = "43",
pages = "184--193",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "1-2",

}

TY - JOUR

T1 - Bronchial thermoplasty

T2 - A new treatment paradigm for severe persistent asthma

AU - Cayetano, Katherine S.

AU - Chan, Andrew

AU - Albertson, Timothy E

AU - Yoneda, Ken Y

PY - 2012/8

Y1 - 2012/8

N2 - Patients with severe asthma represent only a minority of the total asthma population; however, they account for the majority of the mortality, morbidity, and health care-related cost of this chronic illness. Bronchial thermoplasty is a novel treatment modality that employs radiofrequency energy to alter the smooth muscles of the airways. This therapy represents a radical change in our treatment paradigm from daily repetitive dosing of medications to a truly long-term and potentially permanent attenuation of perhaps the most feared component of asthma - smooth muscle-induced bronchospasm. A large, multicentered, double-blinded, randomized controlled trial employed the unprecedented (but now industry standard for bronchoscopic studies) approach of using sham bronchoscopy as a control. It demonstrated that bronchial thermoplasty is safe, improved quality of life, and decreased frequency of severe exacerbations in the treatment group compared to the control group. Although the mechanism of action of bronchial thermoplasty is not currently completely understood, it should be considered as a valid and potentially valuable option for patients who have severe persistent asthma and who remain symptomatic despite inhaled corticosteroids and long-acting beta-2 agonists. Such patients should however be carefully evaluated at centers with expertise in managing severe asthma patients and with physicians who have experience with this promising new treatment modality.

AB - Patients with severe asthma represent only a minority of the total asthma population; however, they account for the majority of the mortality, morbidity, and health care-related cost of this chronic illness. Bronchial thermoplasty is a novel treatment modality that employs radiofrequency energy to alter the smooth muscles of the airways. This therapy represents a radical change in our treatment paradigm from daily repetitive dosing of medications to a truly long-term and potentially permanent attenuation of perhaps the most feared component of asthma - smooth muscle-induced bronchospasm. A large, multicentered, double-blinded, randomized controlled trial employed the unprecedented (but now industry standard for bronchoscopic studies) approach of using sham bronchoscopy as a control. It demonstrated that bronchial thermoplasty is safe, improved quality of life, and decreased frequency of severe exacerbations in the treatment group compared to the control group. Although the mechanism of action of bronchial thermoplasty is not currently completely understood, it should be considered as a valid and potentially valuable option for patients who have severe persistent asthma and who remain symptomatic despite inhaled corticosteroids and long-acting beta-2 agonists. Such patients should however be carefully evaluated at centers with expertise in managing severe asthma patients and with physicians who have experience with this promising new treatment modality.

KW - Airway smooth muscle

KW - Bronchial thermoplasty

KW - Radiofrequency energy

KW - Refractory asthma

KW - Severe asthma

UR - http://www.scopus.com/inward/record.url?scp=84871648111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871648111&partnerID=8YFLogxK

U2 - 10.1007/s12016-011-8295-6

DO - 10.1007/s12016-011-8295-6

M3 - Article

C2 - 22105704

AN - SCOPUS:84871648111

VL - 43

SP - 184

EP - 193

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 1-2

ER -